rs12301915

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_002834.5(PTPN11):​c.1093-9C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0163 in 1,558,590 control chromosomes in the GnomAD database, including 577 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). The gene PTPN11 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.039 ( 264 hom., cov: 32)
Exomes 𝑓: 0.014 ( 313 hom. )

Consequence

PTPN11
NM_002834.5 intron

Scores

2
Splicing: ADA: 0.006815
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:20

Conservation

PhyloP100: 0.853

Publications

8 publications found
Variant links:
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]
PTPN11 Gene-Disease associations (from GenCC):
  • LEOPARD syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • metachondromatosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 12-112482065-C-A is Benign according to our data. Variant chr12-112482065-C-A is described in ClinVar as Benign. ClinVar VariationId is 40542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
NM_002834.5
MANE Select
c.1093-9C>A
intron
N/ANP_002825.3
PTPN11
NM_001330437.2
c.1093-9C>A
intron
N/ANP_001317366.1Q06124-1
PTPN11
NM_001374625.1
c.1090-9C>A
intron
N/ANP_001361554.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
ENST00000351677.7
TSL:1 MANE Select
c.1093-9C>A
intron
N/AENSP00000340944.3Q06124-2
PTPN11
ENST00000635625.1
TSL:5
c.1093-9C>A
intron
N/AENSP00000489597.1Q06124-1
PTPN11
ENST00000392597.5
TSL:1
c.1093-9C>A
intron
N/AENSP00000376376.1Q06124-3

Frequencies

GnomAD3 genomes
AF:
0.0390
AC:
5934
AN:
152096
Hom.:
262
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0237
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00828
Gnomad SAS
AF:
0.00953
Gnomad FIN
AF:
0.0111
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0325
GnomAD2 exomes
AF:
0.0181
AC:
4555
AN:
251222
AF XY:
0.0160
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.0141
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00962
Gnomad FIN exome
AF:
0.0141
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.0168
GnomAD4 exome
AF:
0.0139
AC:
19496
AN:
1406376
Hom.:
313
Cov.:
31
AF XY:
0.0134
AC XY:
9417
AN XY:
702406
show subpopulations
African (AFR)
AF:
0.114
AC:
3649
AN:
32054
American (AMR)
AF:
0.0148
AC:
662
AN:
44596
Ashkenazi Jewish (ASJ)
AF:
0.00267
AC:
69
AN:
25818
East Asian (EAS)
AF:
0.00531
AC:
209
AN:
39388
South Asian (SAS)
AF:
0.00991
AC:
842
AN:
84996
European-Finnish (FIN)
AF:
0.0133
AC:
710
AN:
53332
Middle Eastern (MID)
AF:
0.0211
AC:
119
AN:
5636
European-Non Finnish (NFE)
AF:
0.0114
AC:
12084
AN:
1062078
Other (OTH)
AF:
0.0197
AC:
1152
AN:
58478
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
933
1865
2798
3730
4663
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0391
AC:
5952
AN:
152214
Hom.:
264
Cov.:
32
AF XY:
0.0377
AC XY:
2805
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.108
AC:
4497
AN:
41504
American (AMR)
AF:
0.0236
AC:
361
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.00849
AC:
44
AN:
5182
South Asian (SAS)
AF:
0.00933
AC:
45
AN:
4824
European-Finnish (FIN)
AF:
0.0111
AC:
117
AN:
10588
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
799
AN:
68028
Other (OTH)
AF:
0.0326
AC:
69
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
271
541
812
1082
1353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0215
Hom.:
165
Bravo
AF:
0.0435
EpiCase
AF:
0.00905
EpiControl
AF:
0.00960

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (10)
-
-
2
Metachondromatosis (2)
-
-
2
not provided (2)
-
-
2
RASopathy (2)
-
-
1
Juvenile myelomonocytic leukemia (1)
-
-
1
LEOPARD syndrome 1 (1)
-
-
1
Noonan syndrome 1 (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
15
DANN
Benign
0.76
PhyloP100
0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0068
dbscSNV1_RF
Benign
0.11
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12301915; hg19: chr12-112919869; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.